SCHEMBL220287

SCHEMBL220287

CC(C)c1cccc(C(C)C)c1N1[C]N(c2c(C(C)C)cccc2C(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRB2 P47870 2/20 0.41
TSHR P16473 2/20 0.41
FAAH O00519 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
GABRB1 P18505 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2C P28335 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
HTR2B P41595 1/20 0.41
GABRA2 P47869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8039172 0.87 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL19206406 0.87 TSHR (0.34) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL1005044 0.76 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL29282852 0.76 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL14744528 0.76 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL14221891 0.76 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL13850355 0.73 GABRA1 (0.40) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL17310016 0.72 GABRA1 (0.43) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL8990154 0.72 GABRA1 (0.43) GABRA1GABRG2GABRB3GABRB2TSHR
SCHEMBL222225 0.72 GABRA1 (0.43) GABRA1GABRG2GABRB3GABRB2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016991-B1 LIQUID MOLDING COMPOSITIONS MATERIA INC (US) 2024-06-12 EP claimed
US-20240116039-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE UMICORE AG & CO. KG (DE) 2024-04-11 US claimed
EP-3256505-B1 CYCLIC OLEFIN RESIN COMPOSITIONS COMPRISING FUNCTIONAL ELASTOMERS MATERIA INC (US) 2023-11-29 EP claimed
US-20230149911-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE UMICORE AG & CO. KG (DE) 2023-05-18 US claimed
US-11577232-B2 Ruthenium-based metathesis catalysts, precursors for their preparation and their use UMICORE AG & CO. KG (DE) 2023-02-14 US claimed
US-20220118434-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE UMICORE AG & CO. KG (DE) 2022-04-21 US claimed
US-11241680-B2 Ruthenium-based metathesis catalysts, precursors for their preparation and their use UMICORE AG & CO. KG 2022-02-08 US claimed
US-20210403654-A1 ADHESION PROMOTER COMPOSITIONS FOR CYCLIC OLEFIN RESIN COMPOSITIONS MATERIA, INC. (US) 2021-12-30 US claimed
US-10907018-B2 Adhesion promoter compositions for cyclic olefin resin compositions MATERIA, INC. (US) 2021-02-02 US claimed
US-10711090-B2 Thermal insulation MATERIA, INC. (US) 2020-07-14 US claimed
US-7504465-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-17 US claimed
US-20090062475-A1 Production of elastomeric functionalized olefin polymers EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2009-03-05 US claimed
US-20080312393-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof BAUGH LISA S 2008-12-18 US claimed
US-7268233-B2 Nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions UMICORE AG & CO. KG (DE) 2007-09-11 US claimed
EP-1526917-B1 NOVEL NICKEL-CARBENE, PALLADIUM-CARBENE AND PLATINUM-CARBENE COMPLEXES, THEIR PRODUCTION AND USE IN CATALYTIC REACTIONS UMICORE AG & CO KG (DE) 2007-03-14 EP claimed
EP-1704172-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF ExxonMobil Research and Engineering Company (US) 2006-09-27 EP claimed
US-20060128935-A1 Manufacture of macrocyclic polyester oligomers E. I. DU PONT DE NEMOURS AND COMPANY 2006-06-15 US claimed
US-20060122398-A1 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions UMICORE AG & CO. KG (DE) 2006-06-08 US claimed
WO-2005063834-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-07-14 WO claimed
US-20050137369-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-06-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11241680-B2 Ruthenium-based metathesis catalysts, precursors for their preparation and their use HMBS, RRP12, RNF168 GABRA1 3066/4885GABRG2 3496/4885GABRB3 2335/4885
US-20230149911-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE HMBS, RRP12, RNF168 GABRA1 3066/4885GABRG2 3496/4885GABRB3 2335/4885
US-11577232-B2 Ruthenium-based metathesis catalysts, precursors for their preparation and their use HMBS, RRP12, RNF168 GABRA1 3066/4885GABRG2 3496/4885GABRB3 2335/4885
US-20240116039-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE HMBS, RRP12, RNF168 GABRA1 3066/4885GABRG2 3496/4885GABRB3 2335/4885
US-20220118434-A1 RUTHENIUM-BASED METATHESIS CATALYSTS, PRECURSORS FOR THEIR PREPARATION AND THEIR USE HMBS, RRP12, RNF168 GABRA1 3066/4885GABRG2 3496/4885GABRB3 2335/4885
US-20060122398-A1 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions PPOX, PDCD1, PDCD1LG2 GABRA1 4236/4885GABRG2 4208/4885GABRB3 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.